RxDoctor Payments Data

Kara Jolly, MD

Pediatrics · Mattoon, ILNPI 1659831071

Payments from drug & device makers

$1,806in general payments, 2019–2025

Across 105 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$348
  • GSK$227
  • Novartis$220
  • AstraZeneca$201
  • Pfizer$136
  • Dexcom, Inc.$125
  • plus $550 from 11 others

What the payments were for

  • Food & beverage$1,806100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,806 in reported general payments places this provider in the 90th percentile of 2,058 pediatrics providers in Illinois.

See all pediatrics providers in Illinois

Medicare billing

Part B allowed, 2024
$61,933
Medicare patients
231
Services billed
905

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide120$113,072
JardianceEmpagliflozin144$108,072
Trelegy ElliptaFluticasone/Umeclidin/Vilanter108$78,374
EliquisApixaban54$48,041
RybelsusSemaglutide30$40,860
TrulicityDulaglutide37$35,210
XareltoRivaroxaban15$19,197
FarxigaDapagliflozin Propanediol16$15,273
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$14,687
JanuviaSitagliptin Phosphate16$12,259
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog33$11,597
MounjaroTirzepatide11$11,489
Janumet XrSitagliptin Phos/Metformin Hcl11$6,262
DuleraMometasone/Formoterol11$3,738
Atorvastatin Calcium277$3,179

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$348$153,932150 claims
Boehringer IngelheimJardiance$21$108,072144 claims
GSKTrelegy Ellipta$227$78,374108 claims
PfizerEliquis$136$48,04154 claims
Lilly USA, LLCTrulicity, Mounjaro$115$46,69848 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$201$32,61449 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,058 pediatrics providers in Illinois.

Other pediatrics in Mattoon

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →